Document Classification

Section Type: RESULTS

Text: After treatment, that increased of CD3 +, CD4 +, CD4 + / CD8 + increased (62. 25 + / -10. 01 % vs 68. 31 + / -9. 72 %, 36. 83 + / -10. 44 % vs 42. 6 + / -9. 62 %, 1. 24 + / -0. 65 vs 1. 66 + / -0. 85, P < 0. 05) and the values of CD8 + and sIL-2R decreased obviously (33. 06 + / -7. 69 % vs 29. 24 + / -6. 25 %, 588. 23 + / -216. 86 U/mL vs 475. 87 + / -211. 36 U/mL, P < 0. 05) in the treatment group, whereas these values were opposite in the control group (64. 22 + / -6. 91 % vs 60. 63 + / -5. 75 %, 35. 62 + / -7. 49 % vs 31. 53 + / -5. 53 %, 32. 95 + / -8. 28 % vs 37. 14 + / -7. 48 %, 1. 17 + / -0. 43 vs 0. 94 + / -0. 43, 573. 63 + / -214. 32 U/mL vs 692. 17 + / -221. 33 U/mL, P < 0. 05).